Lactobacillus paracasei strain
US-12152232-B2 · Nov 26, 2024 · US
Lactobacillus plantarum and composition comprising the same
US10093995B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10093995-B2 |
| Application number | US-201013503800-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 27, 2010 |
| Priority date | Oct 28, 2009 |
| Publication date | Oct 9, 2018 |
| Grant date | Oct 9, 2018 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Lactobacillus plantarum CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprising Lactobacillus plantarum CJLP243, and a composition for enhancing immune response comprising Lactobacillus plantarum CJLP243.
First claim
Opening claim text (preview).
The invention claimed is: 1. A bacterial composition, comprising: Lactobacillus plantarum CJLP243 strain KCCM 11045P and an effective amount of a lyophilization protecting agent, wherein the bacterial composition is a freeze-dried composition. 2. The bacterial composition of claim 1 , wherein the cryoprotectant is selected from the group consisting of skim milk and dextrin. 3. A pharmaceutical composition, comprising the bacterial composition of claim 1 and a suitable pharmaceutically acceptable excipient or additive. 4. The pharmaceutical composition of claim 3 , wherein a formulation of the pharmaceutical composition is selected from the group consisting of liquids, suspensions, powder, granules, tablets, capsules, pills and extracts. 5. A food composition, comprising the bacterial composition of claim 1 and a food. 6. The food composition of claim 5 , further comprising sitologically acceptable excipient or additive. 7. A livestock feed composition, comprising the bacterial composition of claim 1 and a livestock feed. 8. A livestock feed additive, comprising the bacterial composition of claim 1 and an organic acid or a natural antioxidant. 9. A cosmetic, comprising the bacterial composition of claim 1 and a cosmetic excipient or additive. 10. The composition of claim 1 , suitable for use in treatment of intestinal disease. 11. The composition of claim 10 , wherein the intestinal disease is selected from the group consisting of infectious diarrhea caused by pathogenic microorganisms, gastroenteritis, inflammatory bowel disease, psychogenic enteritis syndrome, overgrowth of microorganisms in the small intestine and diarrhea. 12. The composition of claim 1 , suitable for use in treatment of immune disease. 13. The composition of claim 12 , wherein the immune disease is selected from the group consisting of allergic diseases, atopy, cancer and autoimmune diseases.
Assignees
Inventors
Classifications
Drugs for immunological or allergic disorders · CPC title
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics · CPC title
Antineoplastic agents · CPC title
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Immunosuppressants, e.g. drugs for graft rejection · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10093995B2 cover?
- Lactobacillus plantarum CJLP243 (KCTC 11045P), a composition for treating intestinal diseases comprising Lactobacillus plantarum CJLP243, and a composition for enhancing immune response comprising Lactobacillus plantarum CJLP243.
- Who is the assignee on this patent?
- Kim Bong Joon, Jung Heon Woong, Lee Kang Pyo, and 5 more
- What technology area does this patent fall under?
- Primary CPC classification A61K35/747. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).